Helicobacter pylori infection secondary prevention: Difference between revisions
No edit summary |
No edit summary |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
The secondary prevention strategies following ''[[H. pylori]]'' infection to prevent recurrence of [[peptic ulcer disease]] and [[gastric cancer]] include the use of [[antibiotics]] to prevent recurrence of [[infection]] and the post treatment confirmation of ''[[H. pylori]]'' eradication after treatment using diagnostic tests. | |||
==Secondary Prevention== | ==Secondary Prevention== | ||
*Secondary prevention strategies following ''[[H. pylori]]'' infection to prevent recurrence of [[peptic ulcer disease]] and [[gastric cancer]] include: | *Secondary prevention strategies following ''[[H. pylori]]'' infection to prevent recurrence of [[peptic ulcer disease]] and [[gastric cancer]] include:<ref name="pmid21180520">{{cite journal| author=Lee YC, Liou JM, Wu MS, Wu CY, Lin JT| title=Eradication of helicobacter pylori to prevent gastroduodenal diseases: hitting more than one bird with the same stone. | journal=Therap Adv Gastroenterol | year= 2008 | volume= 1 | issue= 2 | pages= 111-20 | pmid=21180520 | doi=10.1177/1756283X08094880 | pmc=3002494 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21180520 }} </ref><ref name="pmid17170018">{{cite journal| author=Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D et al.| title=Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. | journal=Gut | year= 2007 | volume= 56 | issue= 6 | pages= 772-81 | pmid=17170018 | doi=10.1136/gut.2006.101634 | pmc=1954853 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17170018 }} </ref> | ||
:*Use of antibiotics to prevent recurrence of infection | :*Use of [[antibiotics]] to prevent recurrence of [[infection]] | ||
:*Post treatment confirmation of ''[[H. pylori]]'' eradication after treatment. | :*Post treatment confirmation of ''[[H. pylori]]'' eradication after treatment using diagnostic tests. | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Latest revision as of 04:21, 24 January 2017
|
Helicobacter pylori infection Microchapters |
|
Differentiating Helicobacter pylori infection from other Diseases |
|---|
|
Diagnosis |
|
Guideline Recommendation |
|
Treatment |
|
Case Studies |
|
Helicobacter pylori infection secondary prevention On the Web |
|
American Roentgen Ray Society Images of Helicobacter pylori infection secondary prevention |
|
Helicobacter pylori infection secondary prevention in the news |
|
Directions to Hospitals Treating Helicobacter pylori infection |
|
Risk calculators and risk factors for Helicobacter pylori infection secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yamuna Kondapally, M.B.B.S[2]
Overview
The secondary prevention strategies following H. pylori infection to prevent recurrence of peptic ulcer disease and gastric cancer include the use of antibiotics to prevent recurrence of infection and the post treatment confirmation of H. pylori eradication after treatment using diagnostic tests.
Secondary Prevention
- Secondary prevention strategies following H. pylori infection to prevent recurrence of peptic ulcer disease and gastric cancer include:[1][2]
- Use of antibiotics to prevent recurrence of infection
- Post treatment confirmation of H. pylori eradication after treatment using diagnostic tests.
References
- ↑ Lee YC, Liou JM, Wu MS, Wu CY, Lin JT (2008). "Eradication of helicobacter pylori to prevent gastroduodenal diseases: hitting more than one bird with the same stone". Therap Adv Gastroenterol. 1 (2): 111–20. doi:10.1177/1756283X08094880. PMC 3002494. PMID 21180520.
- ↑ Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D; et al. (2007). "Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report". Gut. 56 (6): 772–81. doi:10.1136/gut.2006.101634. PMC 1954853. PMID 17170018.